Veradigm Presentations at ISPOR 2022 Highlight Broader Access to and Integration of Real-world Data Sources

May 11, 2022

Covid-19 Dashboard highlights risk factors for unvaccinated, vaccination gaps, and social disparities

CHICAGO--(BUSINESS WIRE)--May 11, 2022-- Researchers from Veradigm®, a leading provider of healthcare data and technology solutions, will present health economics and outcomes research (HEOR) data on Covid-19, diabetes, NASH (Non-Alcoholic Steatohepatitis), and cardiovascular disease at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) in Washington, D.C. from May 15-18, 2022.

This press release features multimedia. View the full release here:

“Accessing real-world data from across a variety of sources provides rich evidence for better decision-making and improved clinical outcomes for patients,” said Tom Langan, Allscripts President and Chief Commercial Officer. “We’re pleased to demonstrate how Veradigm provides tools that contribute to public health initiatives, like the Covid-19 Dashboard guiding outreach to underserved communities, or identifying risk factors with research that supports patients diagnosed with NASH earlier in their diagnosis or treatment.”

Key data presentations at ISPOR 2022 include:


Real-World Data Dashboard Integrating Public Health & EHR Data for Identifying COVID-19 Vaccination Gaps in the US. L. Kallenbach. CODE: EPH60. May 17th 9:45 AM1:15 PM EDT.

SARS-COV-2 Vaccine Breakthrough Infection Rates Based Data from 3 EHRS. J. Overcash. CODE: RWD72. May 17th 9:45 AM1:15 PM EDT.


Assessing Cardiovascular Disease (CVD) Risk By Fibrosis Stage Defined By Fibrosis-4 (FIB-4) Among Patients with Non-Alcoholic Steatohepatitis (NASH) Using Real World Data (RWD). A. Bogdanov. CODE: EPH141. May 18th 9:00 AM12:45 PM EDT.

Comparing Fibrosis Staging Approaches Among Patients with Non-Alcoholic Steatohepatitis (NASH) Using Real World Data (RWD). A. Bogdanov. CODE: EPH161. May 16th 3:00 – 6:30 PM EDT.


Comparing Techniques for Mining HBA1C Data in Ambulatory EHRS for Use in RWE Research. N. Nguyen. CODE: RWD52. May 16th 3:00 - 6:30 PM EDT.

Artificial Intelligence (AI)

Categorizing Telemedicine Visits Using Natural Language Processing and Machine Learning. T. Sudaria. CODE: RWD112. May 17th 3:00 - 6:30 PM EDT.

Evaluating a Privacy Preserving Record Linkage (PPRL) Solution to Link De-identified Patient Records in RWD Using Default Matching Methods and Machine Learning Methods. N. Nguyen. CODE: RWD103. May 17th 3:00 - 6:30 PM EDT.

Additional presentations at ISPOR include Veradigm’s Comparing Registry and Electronic Health Record (EHR) Data for Real-World Evidence Generation: Heart Failure as a Case Study on Tuesday, May 17 at 12:45 p.m. EDT. This presentation examines how generating real-world evidence (RWE) from heart failure patients requires clinical data elements not commonly found in administrative databases and has the potential to further understanding in heart failure management. Data were compared and contrasted from two different data sources, Veradigm’s PINNACLE® Registry, a large cardiovascular disease registry developed by the American College of Cardiology, with those identified in the Practice Fusion ambulatory electronic health record (EHR) database.

For more presentation information titles, please visit ISPOR 2022.

About Veradigm®

Veradigm® is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. Some healthcare technology companies deliver clinical data for biopharma and health plans, some help turn that data into insights, others serve healthcare providers directly by providing point-of-care clinical software and patient outreach platforms. Only Veradigm does it all. In combination with Veradigm’s companies and solutions, the Veradigm Network features a dynamic community of companies providing advanced insights, technology, and data-driven solutions, all working together to transform healthcare insightfully.

For more information on Veradigm, visit, or find Veradigm on LinkedIn, Facebook, Twitter, and YouTube.

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

© 2022 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

Jenny Gelinas

Concetta Rasiarmos

Source: Allscripts

Contact Investor Relations

Jenny Gelinas
Vice President, Investor Relations